Am J Transplant, Volume 20, Suppl 3 Archives - Page 84 of 223 - ATC Abstracts

2020 American Transplant Congress
Comparison of Six-Month Outcomes in Patients Bridged to Heart Transplantation with Percutaneous Temporary Circulatory Support Before and after the UNOS Allocation System Change
J. Nattiv¹, G. S. Liu¹, P. Banankhah¹, J. Sussex¹, P. Genyk¹, J. Li¹, D. Vucicevic², R. S. Chand³, K. Pandya¹, J. Rahman¹, A. M. Wolfson⁴, A. S. Vaidya¹, E. DePasquale¹
¹Keck Hospital of USC, Los Angeles, CA, ²Newark Beth Israel Medical Center, Newark, NJ, ³Harbor UCLA Medical Center, Los Angeles, CA, ⁴University of Arizona Sarver Heart Center, Tucson, AZ
*Purpose: We report the trends in utilization and outcomes of percutaneous temporary circulatory support (TCS) in the forms of Impella or TandemHeart as a bridge…
2020 American Transplant Congress
Alterations in Left Ventricular Wall Thickness after Cardiac Transplantation
C. K. Alvarez, O. Saeed, S. R. Patel, E. Borukhov, U. Jorde
Advanced Heart Failure, Transplant and Mechanical Circulatory Support, Montefiore Medical Center, Albert Einstein, Bronx, NY
*Purpose: We investigated changes in cardiac wall thickness of donor hearts over time, including the peri-operative OHT period (within 4 days after transplantation) and up…
2020 American Transplant Congress
Monitoring the Removal of Donation Service Area from Lung Allocation
R. R. Goff¹, R. Daly², E. D. Lease³
¹Research, United Network for Organ Sharing, Richmond, VA, ²Mayo Clinic, Rochester, MN, ³University of Washington, Seattle, WA
*Purpose: In 2017 the Organ Procurement and Transplantation Network (OPTN) altered US lung allocation policy by replacing the donor service area (DSA) with a 250…
2020 American Transplant Congress
Anticoagulation in Simultaneous Pancreas Kidney (SPK) Transplantation- On What Basis?
J. Gopal, P. Herbert, J. Crane, F. Dor, V. Papalois, A. Muthusamy
Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
*Purpose: Despite technical refinements, early pancreas graft loss due to thrombosis continues to occur. Conventional coagulation tests do not detect hypercoagulability and hence is left…
2020 American Transplant Congress
The Role of Complement-Split Products as Biomarkers for Acute Antibody-Mediated Rejection of Kidney Allografts
B. G. Abu Jawdeh¹, B. Campos-Naciff¹, K. Harrison¹, K. Meganathan¹, A. Kumar², M. Anand¹, A. Govil¹, E. S. Woodle¹, B. P. Dixon³
¹University of Cincinnati, Cincinnati, OH, ²All India Institute of Medical Sciences, New Delhi, India, ³University of Colorado, Aurora, CO
*Purpose: Acute antibody-mediated rejection (AMR) is mediated by the activation of the classical complement system in addition to non-complement dependent inflammatory pathways. Complement fixation by…
2020 American Transplant Congress
The Protective Effect of Hypothermic Oxygenated Machine Perfusion (HOPE) Onresuscitating Steatotic Liver and its Underlying Mechanism
F. Lin¹, F. Zhen¹, X. Yan¹, L. Wenjin¹, Y. Qifa²
¹Zhongnan Hospital of Wuhan University, Wuhan, China, ²Zhongnan Hospital of Wuhan University/The Third Xiangya Hospital of Central South University, Wuhan/Changsha, China
*Purpose: To analyze the impact of steatotic livers with conventional cold storage (CS) and hypothermic oxygenated perfusion (HOPE) approaches, and further to investigate the rescue…
2020 American Transplant Congress
Circulating MicroRNA Signatures in Chronic Pancreatitis Patients Undergoing Total Pancreatectomy with Islet Transplantation
S. Vasu, C. M. Darden, K. Kumano, M. Lawrence, B. Naziruddin
Baylor University Medical Ctr, Dallas, TX
*Purpose: Chronic pancreatitis (CP) is characterized by exocrine insufficiency and severe abdominal pain. Total pancreatectomy with islet autotransplantation (TPIAT) relieves chronic pain and aids restoration…
2020 American Transplant Congress
Evaluating Preformed Donor HLA Reactive T Cells Using PIRCHE-II Algorithm
T. Tomosugi¹, K. Iwasaki², S. Sakamoto¹, A. Kanda¹, K. Futamura¹, M. Okada¹, T. Hiramitsu¹, N. Goto¹, S. Narumi¹, Y. Watarai¹, T. Kobayashi², M. Niemann³, E. Spierings⁴
¹Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan, ²Kidney Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan, ³PIRCHE AG, Berlin, Germany, ⁴University Medical Center Utrecht, Utrecht, Netherlands
*Purpose: De novo donor-specific HLA antibodies (dnDSA) production involves the indirect allorecognition pathway in which recipient CD4+T cells recognize donor-HLA-derived peptide and recipient HLA class…
2020 American Transplant Congress
Risk Factors for Early Multidrug-Resistant Infections in Solid Organ Transplant Recipients: How Impactful Are Donor-Derived Infections?
T. T. Miller¹, E. J. Kwak², G. Floridia³, F. Tuzzolino³, A. Luca³, A. Mularoni³
¹School of Medicine, University of Pittsburgh, Pittsburgh, PA, ²Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, ³Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (IRCCS-ISMETT), Palermo, Italy
*Purpose: The purpose of this study is to evaluate risk factors for early post-transplant infections by multi-drug resistant gram-negative bacilli (MDRGNB).*Methods: We retrospectively assessed the…
2020 American Transplant Congress
The Trend of Non-Utilization and Decline of Hepatitis C Virus Antibody-Positive Deceased Donor Kidneys
S. Chang¹, K. Lentine², D. Axelrod³, J. Wellen¹, M. Wang¹, M. A. Schnitzler⁴, T. Alhamad⁵
¹Surgery, Washington University School of Medicine, Saint Louis, MO, ²Surgery, Saint Louis University, Saint Louis, MO, ³Surgery, University of Iowa, Iowa City, IA, ⁴Surgery, Sanit Louis University, Saint Louis, MO, ⁵Washington University School of Medicine, Saint Louis, MO
*Purpose: With more transplant centers are accepting hepatitis C virus infected (HCV+) deceased donor kidneys (dHCV+), the trend of non-utilization and decline of these organs…